Fortress Biotech, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Fortress Biotech, Inc. (FBIO) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$7.16 million for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2021-04-09
- Fortress Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-12-31 was -$1.57M, a 605.48% decline year-over-year.
- Fortress Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-09-30 was -$2.76M.
- Fortress Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-06-30 was -$1.06M.
- Fortress Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-03-31 was -$1.78M, a 116.06% decline year-over-year.
- Fortress Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2020 was -$7.16M, a 202.23% decline from fiscal 2019.
- Fortress Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2019 was $7.01M, a 22.49% decline from fiscal 2018.
- Fortress Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2018 was $9.04M.
- Fortress Biotech, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$40.22M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 93 month |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$1.57M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-09 | -$4.33M derived: sum of 2 quarters · filed 2021-04-09 | -$5.39M derived: sum of 3 quarters · filed 2021-04-09 | -$7.16M 10-K/A · filed 2021-04-09 | ||||
| 2020-09-30 | -$2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$3.82M derived: sum of 2 quarters · filed 2020-11-09 | -$5.60M 10-Q · filed 2020-11-09 | -$5.29M derived: sum of 4 quarters · filed 2021-04-09 | ||||
| 2020-06-30 | -$1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$2.84M 10-Q · filed 2020-08-10 | -$2.53M derived: sum of 3 quarters · filed 2021-04-09 | -$6.28M derived: sum of 4 quarters · filed 2021-04-09 | ||||
| 2020-03-31 | -$1.78M 10-Q · filed 2020-05-11 | -$1.47M derived: sum of 2 quarters · filed 2021-04-09 | -$5.22M derived: sum of 3 quarters · filed 2021-04-09 | -$5.83M derived: sum of 4 quarters · filed 2021-04-09 | ||||
| 2019-12-31 | $310.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-09 | -$3.44M derived: sum of 2 quarters · filed 2021-04-09 | -$4.05M derived: sum of 3 quarters · filed 2021-04-09 | $7.01M 10-K/A · filed 2021-04-09 | ||||
| 2019-09-30 | -$3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$4.36M derived: sum of 2 quarters · filed 2020-11-09 | $6.70M 10-Q · filed 2020-11-09 | $10.44M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$611.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $10.45M 10-Q · filed 2020-08-10 | $14.19M derived: sum of 3 quarters · filed 2020-08-10 | $23.52M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $11.06M 10-Q · filed 2020-05-11 | $14.80M derived: sum of 2 quarters · filed 2020-05-11 | $24.13M derived: sum of 3 quarters · filed 2020-05-11 | $21.94M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $13.07M derived: sum of 2 quarters · filed 2020-03-16 | $10.88M derived: sum of 3 quarters · filed 2020-03-16 | $9.04M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $9.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $7.14M derived: sum of 2 quarters · filed 2019-11-12 | $5.30M 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | -$2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$4.03M 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | -$1.84M 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | -$40.22M 10-K · filed 2019-03-18 | |||||||
| 2017-06-30 | -$20.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$21.16M 10-Q · filed 2017-08-09 | -$22.47M derived: sum of 3 quarters · filed 2017-08-09 | -$20.30M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2017-03-31 | -$942.00K 10-Q · filed 2017-05-10 | -$2.25M derived: sum of 2 quarters · filed 2017-05-10 | -$81.00K derived: sum of 3 quarters · filed 2017-05-10 | -$4.30M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $861.00K derived: sum of 2 quarters · filed 2017-03-16 | -$3.36M derived: sum of 3 quarters · filed 2017-08-09 | -$6.06M 10-K · filed 2017-03-16 | ||||
| 2016-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$2.05M derived: sum of 2 quarters · filed 2017-08-09 | -$4.75M 10-Q · filed 2016-11-09 | $34.47M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-06-30 | -$4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$6.92M 10-Q · filed 2017-08-09 | $32.30M derived: sum of 3 quarters · filed 2017-08-09 | $11.00M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | -$2.70M 10-Q · filed 2017-05-10 | $36.52M derived: sum of 2 quarters · filed 2017-05-10 | $15.22M derived: sum of 3 quarters · filed 2017-05-10 | $13.47M derived: sum of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | $39.22M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $17.92M derived: sum of 2 quarters · filed 2017-03-16 | $16.17M derived: sum of 3 quarters · filed 2017-03-16 | $7.88M 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | -$21.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$23.05M derived: sum of 2 quarters · filed 2016-11-09 | -$31.34M 10-Q · filed 2016-11-09 | -$21.41M 10-Q · filed 2015-11-09 | -$54.01M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | -$1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$10.04M 10-Q · filed 2016-08-09 | -$1.41M 10-Q · filed 2015-08-10 | -$32.71M derived: sum of 3 quarters · filed 2017-03-16 | -$32.76M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | -$8.29M 10-Q · filed 2016-05-10 | -$1.36M 10-Q · filed 2015-05-11 | -$30.96M derived: sum of 2 quarters · filed 2017-03-16 | -$31.02M derived: sum of 3 quarters · filed 2017-03-16 | -$31.31M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$22.68M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$22.73M derived: sum of 2 quarters · filed 2017-03-16 | -$23.02M derived: sum of 3 quarters · filed 2017-03-16 | -$23.27M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$345.00K derived: sum of 2 quarters · filed 2015-11-09 | -$595.00K 10-Q · filed 2015-11-09 | -$596.00K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | -$295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$545.00K 10-Q · filed 2015-08-10 | -$546.00K derived: sum of 3 quarters · filed 2016-03-15 | -$467.00K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | -$250.00K 10-Q · filed 2015-05-11 | -$251.00K derived: sum of 2 quarters · filed 2016-03-15 | -$172.00K derived: sum of 3 quarters · filed 2016-03-15 | -$436.00K derived: sum of 4 quarters · filed 2016-03-15 | -$4.60M 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $78.00K derived: sum of 2 quarters · filed 2016-03-15 | -$186.00K derived: sum of 3 quarters · filed 2016-03-15 | -$188.00K 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$185.00K derived: sum of 2 quarters · filed 2014-11-06 | -$187.00K 10-Q · filed 2014-11-06 | |||||
| 2013-06-30 | -$264.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$266.00K 10-Q · filed 2014-08-11 | ||||||
| 2013-03-31 | -$2.00K 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | -$279.00K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |